Centre for Cancer Biomarkers CCBIO

The CCBIO Research School for Cancer Studies

The CCBIO Research School for Cancer Studies (RSCS), which was officially opened in September 2014, focuses on translational cancer research and innovation, including international exchange and mobility as well as ethical-, legal- and societal aspects of cancer research and treatment. The research school courses are available for all interested students within the field of cancer research. The RSCS is directed by Professor and Vice-Rector Anne Christine Johannessen in collaboration with the Director of CCBIO.


Photocollage of photos from CCBIO Research School situations (teaching, lab, microscope, doctor..)
Ingvild Melien/Colourbox/Eli Vidhammer/CCBIO

Main goals and activities

The main goal of the RSCS is to be a scientifically stimulating and inclusive meeting place for junior researchers within various areas of cancer research, ranging from basic medical to paraclinical and clinical research environments with a common focus on translational studies of cancer biomarkers.

PhD candidates and postdoctors get the opportunity to meet renowned international researchers, and the candidates meet each other and deliberate upon their research projects across the established research groups. In order to attain this goal, CCBIO has allocated basic funding to the RSCS. In addition, RSCS has been integrated into CCBIO’s strategic activities like CCBIO Annual Symposium and the CCBIO Monthly Seminars where world leading scientists and opinion leaders give keynote lectures and interact with students and PIs.

Other established RSCS key activities are the CCBIO Junior Scientist Symposium where junior scientists from CCBIO and beyond meet four times each year to present and discuss their research. A series of specially designed courses have been planned and was launched in early 2015. Apart from the main focus on relevant biomarker studies, PhD candidates are to be trained in inter-disciplinary collaboration, and ethical, economic and societal aspects pertaining to CCBIOs research.

CCBIO also aims to actively use its international networks to provide the ground for exchange of PhD candidates and post doctors both to and from CCBIO. The RSCS will collaborate with local and national research schools.


Courses currently running or established

All courses are open according to available capacity, albeit giving CCBIO´s PhD candidates first right of entry in case of capacity problems. The below list CCBIO Research School for Cancer Studies denotes CCBIO’s courses approved by the UiB. The courses  will run once a year or every second year, apart from CCBIO901 and CCBIO902 which run continiously.

  • CCBIO 901- CCBIO Junior Scientist Symposium.  PhDs and PDs present their results four times a year. Postdocs are chairing the meeting and discussions after each presentation. Read about the first symposia.

  • CCBIO 902 CCBIO Seminar and Symposium Series. This course combines the monthly CCBIO Seminar series with the CCBIO Annual Symposium to make a 3 point 900-level course.
  • CCBIO 903 Cancer Research: Ethical, economical and societal aspects. The course focuses on ethical, economical and societal aspects of cancer and cancer research and aims to equip PhD candidates with tools for systematic reflection on their own and related research as well as methods for assessing the cost benefit of health measures and methods of treatment. Read article: CCBIO focusses on Ethics and Prioritization in new PhD course
  • BMED 904 Biomedical Research Course: Matrix Biology. This is an established course where CCBIO members will now have first right of entry.
  • CCBIO 905 Methods in Cancer Biomarker Research. This course has focus on the full panel of advanced and standard methods with relevance for cancer biomarkers. The intention is a methodological course that also includes components of ethics and economy. This is a strongly needed course with potential national interest. You can find program here of last year's CCBIO905 course.
  • CCBIO 904 Biomarkers and Tumor Biology in Clinical Practice. The course leaders have experience from equivalent courses arranged by the Norwegian MDs association. CCBIO aims to extend the existing course with a focus also on bio-banking in practice. Read about last year's program here.
  • CCBIO 906 Cancer Genomics. This 3 credit course provides broad understanding of aspects of cancer genome biology and their investigation by next generation sequencing (NGS) technologies. Methods for analysing DNA variation and structure and RNA expression patterns are covered, as well as nuclear and chromatin structure. Also ethical, legal aspects, and hereditary predisposition are taught. This course is new in 2017, and will be held the first time November 1-3 2017.